Home/Filings/4/0001628908-24-000040
4//SEC Filing

Shams Aammaad 4

Accession 0001628908-24-000040

CIK 0001628908other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:18 PM ET

Size

6.8 KB

Accession

0001628908-24-000040

Insider Transaction Report

Form 4
Period: 2024-03-01
Shams Aammaad
Chief Accounting Officer
Transactions
  • Award

    Class A Common Stock

    2024-03-01+7,49157,515 total
  • Tax Payment

    Class A Common Stock

    2024-03-01$34.41/sh2,569$88,39954,946 total
Footnotes (4)
  • [F1]Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
  • [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001815354

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:18 PM ET
Size
6.8 KB